Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Andrew Lewin
ResearcherPublications, citations & collaboration network
Andrew Lewin is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 75 works, 5,634 citations, an h-index of 24 and an i10-index of 43.
75
Works
5,634
Citations
24
h-index
43
i10-index
IDs:OpenAlex
How has Andrew Lewin's publication output changed over time?
ScholarIQpublication output · 1971–2015
Output grew300% over the shown period — from 1 works in 1971 to 4 in 2015.
1
1
1
1
1
1
4
1971199820042005200620092015
What are the most-cited papers on Andrew Lewin?
ScholarIQmost cited works
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode, Robert F. Kushner, Andrew Lewin, Trine Vang Skjøth, Arne Haahr Andreasen, Christine B. Jensen, Ralph A. DeFronzo, for the NN8022-1922 Study Group
JAMA. 20151,150 CitationsOPEN ACCESS
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Bernard Zinman, John Gerich, John B. Buse, Andrew Lewin, Sherwyn Schwartz, Philip Raskin, Paula M. Hale, Milan Zdravkovic, Lawrence Blonde, the LEAD-4 Study Investigators
Diabetes Care. 2009839 CitationsOPEN ACCESS
Initiating Insulin Therapy in Type 2 Diabetes
Philip Raskin, Elsie Allen, Priscilla Hollander, Andrew Lewin, Robert A. Gabbay, Peter Hu, Bruce W. Bode, Alan J. Garber, for the INITIATE Study Group
Diabetes Care. 2005560 CitationsOPEN ACCESS
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Murray Epstein, Gordon H. Williams, Myron H. Weinberger, Andrew Lewin, Scott Krause, Robin Mukherjee, Rajiv Patni, Bruce Beckerman
Clinical Journal of the American Society of Nephrology. 2006458 Citations
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Ralph A. DeFronzo, Andrew Lewin, Sanjay Patel, Dacheng Liu, Renee Kaste, Hans J. Woerle, Uli C. Broedl
Diabetes Care. 2015294 Citations
Related on ScholarIQ
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
Paper
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Paper
Initiating Insulin Therapy in Type 2 Diabetes
Paper
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Paper
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Paper
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
Paper